4th Induced Proximity-Based Drug Discovery Summit
Evvnt Promotion / evvnt
23.07.2024 - 25.07.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Kongressthemen
Whilst PROTACs continue to make headwind, much of the heterobifunctional and monovalent opportunity beyond the ubiquitin proteosome system remains untapped, drawing in new and distinguished biopharma in the race to develop new stabilization, modulation, post-translational modification, and inactivation/activation modalities.
Whilst PROTACs continue to make headwind, much of the heterobifunctional and monovalent opportunity beyond the ubiquitin proteosome system remains untapped, drawing in new and distinguished biopharma in the race to develop new stabilization, modulation, post-translational modification, and inactivation/activation modalities.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2313820-3?pid=4832
Speakers: Andrew Zhang, Director, Chemical Biology, AstraZeneca, Brandon Turunen, Co-Founder and Chief Technology Officer, Solu Therapeutics, and more
URL:
Brochure: https://go.evvnt.com/2313820-3?pid=4832
Speakers: Andrew Zhang, Director, Chemical Biology, AstraZeneca, Brandon Turunen, Co-Founder and Chief Technology Officer, Solu Therapeutics, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2313820-2?pid=4832
Frau Isabella Hunter
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
